Blood Pressure Medication Recall 2026: Which Pills Are Affected?

More than 3,700 bottles of a commonly prescribed blood pressure medication have been recalled across the United States after failing a quality test. If you take medication for high blood pressure, here's what to check on your prescription bottle—and why you shouldn't stop treatment without medical advice.

A routine prescription is something most people rarely think twice about. But for patients managing high blood pressure, a recent nationwide drug recall has raised an important question: Could the medication in their cabinet be affected? Macleods Pharma USA has voluntarily recalled 3,744 bottles of a generic blood pressure medication containing olmesartan medoxomil, amlodipine and hydrochlorothiazide.

The recall began on October 7, 2026, and was classified as a Class II recall by the U.S. Food and Drug Administration (FDA) on October 26. The reason? The tablets failed to meet required dissolution standards, raising concerns about whether they release their active ingredients as intended.

Here's what patients need to know.

Which Blood Pressure Medication Has Been Recalled?

The recall involves a specific generic combination medication containing three ingredients:

• Olmesartan medoxomil: Helps relax blood vessels by blocking the effects of angiotensin II.

• Amlodipine: A calcium channel blocker that helps blood vessels relax.

• Hydrochlorothiazide: A diuretic that helps the body eliminate excess sodium and water.

Together, these ingredients help manage high blood pressure.

The affected tablets contain 40 mg of olmesartan medoxomil, 10 mg of amlodipine and 12.5 mg of hydrochlorothiazide.

The medication contains the same active ingredients as the brand-name drug Tribenzor. However, the current recall concerns specific lots of the generic product distributed by Macleods Pharma USA, not brand-name Tribenzor.

Recalled Blood Pressure Pills: Lot Numbers to Check

According to the FDA enforcement information, the affected products are:

30-count bottles

• Medication: Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablets

• Strength: 40 mg/10 mg/12.5 mg

• NDC: 33342-246-07

• Lot number: 12251163A

• Expiration date: May 31, 2027

• Quantity recalled: 3,528 bottles

90-count bottles

• Medication: Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablets

• Strength: 40 mg/10 mg/12.5 mg

• NDC: 33342-246-10

• Lot number: 12251163B

• Expiration date: May 31, 2027

• Quantity recalled: 216 bottles

The affected products were distributed nationwide.

If your medication has the same name but a different lot number, it is not necessarily part of this particular recall.

Why Were These Blood Pressure Pills Recalled?

The problem is not simply about how the tablets look. It involves how they behave once taken.

According to the FDA's enforcement information, the recalled medication failed dissolution specifications.

In pharmaceutical testing, dissolution refers to how a tablet releases its active ingredients into a liquid environment. This process matters because medication must release its ingredients appropriately for the body to absorb them.

If a tablet does not dissolve as expected, it may not deliver the intended amount of medication at the expected rate.

For someone relying on daily medication to control high blood pressure, that raises concerns about whether treatment is working as intended.

Importantly, the recall does not establish that every affected tablet failed to work or that every patient who took the medication experienced harm.

What Does a Class II FDA Recall Mean?

The FDA classifies drug recalls according to their potential health risks.

A Class II recall means that using the affected product may cause temporary or medically reversible health problems, while the likelihood of serious adverse consequences is considered remote.

In other words, the classification signals a potential safety or quality concern, but it does not automatically mean the medication has caused serious harm.

The FDA also explains that patients using medications involved in Class II recalls can generally continue treatment unless the manufacturer or agency directs otherwise.

However, individual circumstances matter, and patients should speak with a healthcare professional before making changes.

You can learn more through the FDA's official guide to understanding drug recalls.

What Should You Do If You Have the Recalled Medication?

Finding out that a prescription drug has been recalled can be unsettling, especially when it is something you take every day.

But the most important step is not to panic. It is to verify your medication and get professional guidance.

Here's what to do:

1. Check your prescription label. Look for the medication name, strength, manufacturer and lot number.

2. Compare the lot numbers. The affected lots are 12251163A and 12251163B.

3. Contact your pharmacy. If the lot number is not printed on your prescription bottle, your pharmacist may be able to identify the original manufacturer's packaging.

4. Speak with your healthcare provider. Ask whether you need a replacement prescription or another treatment plan.

5. Follow official instructions. Do not discard or return medication without first confirming the appropriate next steps.

Should You Stop Taking Your Blood Pressure Medication?

Do not stop taking prescribed blood pressure medication without speaking to your doctor or pharmacist.

High blood pressure often causes no noticeable symptoms, even when readings are dangerously elevated.

Stopping treatment without an appropriate alternative could leave blood pressure uncontrolled and increase the risk of serious cardiovascular complications.

If your medication matches the recalled lots, contact your pharmacist or prescribing clinician promptly to discuss the safest way to maintain treatment.

How Can You Tell If Your Blood Pressure Medication Is Working?

One of the challenges of hypertension is that people often feel perfectly normal even when their blood pressure is elevated.

That's why regular blood pressure monitoring matters.

If you take medication for hypertension, your healthcare provider may recommend checking your blood pressure at home and keeping a record of your readings.

A single higher-than-usual reading does not necessarily mean your medication is ineffective. However, repeated elevated readings deserve medical attention.

If your blood pressure is above 180/120 mm Hg, repeat the measurement after at least one minute and seek prompt medical guidance if it remains that high. If it is accompanied by symptoms such as chest pain, shortness of breath, weakness or difficulty speaking, call 911.

Is This the Only Blood Pressure Medication Recall in 2026?

No. Other blood pressure medications have also been subject to recalls during 2026, including certain lots of chlorthalidone.

However, each recall involves its own products, manufacturers, lot numbers and quality concerns.

Patients should not assume that all medications containing a particular ingredient have been recalled simply because one manufacturer's product is affected.

The safest approach is to check the exact product information against official recall notices.

The Bottom Line: Check Your Prescription, but Don't Panic

The latest blood pressure medication recall is an important reminder that pharmaceutical quality testing continues even after medicines reach the market.

For patients, the key takeaway is straightforward: check the medication name and lot number, contact your pharmacist if anything matches, and never make sudden changes to prescribed treatment without medical advice.

The recall affects specific lots of a generic combination blood pressure medication—not every blood pressure pill on the market.

Staying informed is important. Staying on a safe, effective treatment plan is even more important.

---

Sources

1. U.S. Food and Drug Administration — Understanding Drug Recalls: What to Know and What to Do

2. AARP — Blood Pressure Drug Recalled Because Tablets May Not Dissolve Properly, November 3, 2026

3. Becker's Hospital Review — 3.7K Bottles of Blood Pressure Medication Recalled, November 2026

4. Good Housekeeping — FDA Announces Another Blood Pressure Medication Recall, November 4, 2026

Medical disclaimer: This article is for informational purposes only and does not replace professional medical advice, diagnosis or treatment.

Published: November 6, 2026